BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
BEGIN:VEVENT
UID:31c5aff905e878fb6869890465aa9f48
DTSTAMP:20260404T100749Z

DTSTART:20240627T150000
DTEND:20240627T160000
SUMMARY:Webinar: From Data to Insights: Leveraging GenAI in Real-World Evidence Studies
DESCRIPTION:In healthcare, GenAI holds immense promise for revolutionizing medical research, diagnosis and treatment. But how can GenAI be utilized in the case of Real-World Evidence (RWE)? And to what extent can one leverage this technology effectively to enhance trial efficiency, improve data analysis capabilities and drive meaningful discoveries?\nIn our Climedo Connect on June 27, 2024, Dragan Mileski (Co-Founder and CTO of Climedo) will explore how to meaningfully apply GenAI across the field of clinical trials, with a specific focus on RWE. \nWhat to expect: \n\nUnderstanding GenAI: Explore the fundamentals of GenAI, including emerging trends and technology outlook, to grasp its potential in transforming RWE studies.\nTop use cases for GenAI in post-market studies: Dive into the practical applications of GenAI in post-market studies, examining its role in drug safety monitoring, comparative effectiveness analysis and more.\nBest practices for incorporating GenAI in clinical research: Learn actionable strategies and best practices for seamlessly integrating GenAI into your trials. \n\nDon't miss this opportunity to gain valuable insights and contribute to the discussion on enhancing collaboration between trial physicians, sponsors, and CROs in clinical trials.

X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">\n<HTML>\n<HEAD>\n<META NAME="Generator" CONTENT="MS Exchange Server version 08.00.0681.000">\n<TITLE></TITLE>\n</HEAD>\n<BODY>\n<!-- Converted from text/rtf format -->\n\n<p>In healthcare, GenAI holds immense promise for revolutionizing medical research, diagnosis and treatment. But how can GenAI be utilized in the case of Real-World Evidence (RWE)? And to what extent can one leverage this technology effectively to enhance trial efficiency, improve data analysis capabilities and drive meaningful discoveries?</p><br /><p>In our Climedo Connect on June 27, 2024, Dragan Mileski (Co-Founder and CTO of Climedo) will explore how to meaningfully apply GenAI across the field of clinical trials, with a specific focus on RWE. </p><br /><p>What to expect: </p><br /><ul><br /><li><strong>Understanding GenAI: </strong>Explore the fundamentals of GenAI, including emerging trends and technology outlook, to grasp its potential in transforming RWE studies.</li><br /><li><strong>Top use cases for GenAI in post-market studies: </strong>Dive into the practical applications of GenAI in post-market studies, examining its role in drug safety monitoring, comparative effectiveness analysis and more.</li><br /><li><strong>Best practices for incorporating GenAI in clinical research: </strong>Learn actionable strategies and best practices for seamlessly integrating GenAI into your trials. </li><br /></ul><br /><p>Don't miss this opportunity to gain valuable insights and contribute to the discussion on enhancing collaboration between trial physicians, sponsors, and CROs in clinical trials.</p>\n\n</BODY>\n</HTML>

LOCATION:
END:VEVENT

END:VCALENDAR
